GlassScriptPhysician profile
Varun Dalmia
NPI 1518601806
$2,662.48
in general payments reported to CMS, 2019-2025
10 companies · $2,282 in 2025
The $2,282 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.65 · 2024: $363 · 2025: $2,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,511 · Food and Beverage: $984 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,510.60 |
| Food and Beverage | $984.38 |
| Education | $167.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,630.21 | 2024-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Terumo Medical Corporation | $288.47 | 2025 | Azur Cx Detachable, Glidesheath Slender, Glidewire |
| Medtronic, INC. | $210.33 | 2025 | Hawkone |
| Silk Road Medical, INC. | $182.53 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Abbott Laboratories | $149.99 | 2025 | Esprit |
| Stryker Corporation | $78.68 | 2025 | Flowtriever |
| Angiodynamics, INC. | $53.06 | 2025 | Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $35.38 | 2025 | Enroute Transcarotid Neuroprotection System |
| Kci USA, INC. | $17.65 | 2023 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Ethicon US, LLC | $16.18 | 2025 | Prolene |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Dalmia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.